Characterization of Interferon Beta -1b-Induced Tolerizing Effect in Dendritic Cells

Clinical trial NCT00630721 · COMPLETED

Trial details

NCT number: NCT00630721
Sponsor: University of North Carolina, Chapel Hill
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2007-09-01
Primary completion: 2010-05-15
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.